首页> 外文期刊>European Journal of Pharmacology: An International Journal >The role of heat shock protein 70 in the protective effect of YC-1 on heat stroke rats
【24h】

The role of heat shock protein 70 in the protective effect of YC-1 on heat stroke rats

机译:热休克蛋白70在YC-1对中暑大鼠保护作用中的作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Heat stroke is a life-threatening illness characterized by an elevated core body temperature. Despite adequate lowering of the body temperature and support treatment of multiple organ-system function, heat stroke is often fatal. 3-(5??-Hydoxymethyl-2??-furyl)-1-benzyl-indazol (YC-1) been identified as an activator of soluble guanylate cyclase. To evaluate whether YC-1 protects multiple organ dysfunctions and improves survival during heat stroke and its mechanism. Male Sprague-Dawley rats untreated or treated with either YC-1 or quercetin (heat shock protein (Hsp) 70 inhibitor) were exposures to heat as a model of heat stroke. The mean arterial pressure (MAP), heart rate, rectal temperature (Tco), survival time, and plasma biochemical data, intracellular Hsp70 and heat shock factor-1 expression were measured. The value of MAP, heart rate and Tco of untreated heat stroke (HS) group were all significantly lower than that of normothermal (NT) group. Biochemical markers evidenced that liver and kidney injuries of HS group were significantly higher than that of NT groups. YC-1 (20 mg/kg) pretreatment with heat stroke (YC-1+HS) group, the MAP and heart rate were return to normal, and the biochemical markers were all significantly recovered to normal. The survival time of HS group, NT group and YC-1+HS group were 21, 480, and 445 min, respectively. The expression of Hsp70 and HSF-1 in liver and renal of YC-1+HS group was significantly higher than that of HS group. All of the protective effects of YC-1 were all significantly suppressed when pretreated with quercetin (400 mg/kg). Results indicate that YC-1 may improve survival due to induce Hsp70 overexpression. ? 2012 Elsevier B.V. All rights reserved.
机译:中暑是一种威胁生命的疾病,其特征是核心体温升高。尽管适当降低体温并支持多种器官系统功能的治疗,但中暑通常是致命的。 3-(5′-羟甲基-2′-呋喃基)-1-苄基吲唑(YC-1)被鉴定为可溶性鸟苷酸环化酶的活化剂。评估YC-1是否能保护多器官功能障碍并改善中暑期间的生存及其机制。未经过YC-1或槲皮素(热休克蛋白(Hsp)70抑制剂)治疗或治疗的雄性Sprague-Dawley大鼠暴露于热中,作为中暑的模型。测量平均动脉压(MAP),心率,直肠温度(Tco),存活时间和血浆生化数据,细胞内Hsp70和热休克因子-1表达。未经治疗的中暑(HS)组的MAP,心率和Tco值均显着低于常温(NT)组。生化指标表明,HS组肝肾损伤明显高于NT组。 YC-1(20 mg / kg)中暑(YC-1 + HS)治疗组,MAP和心率均恢复正常,生化指标均明显恢复正常。 HS组,NT组和YC-1 + HS组的生存时间分别为21、480和445分钟。 YC-1 + HS组肝,肾Hsp70和HSF-1的表达明显高于HS组。用槲皮素(400 mg / kg)预处理后,所有YC-1的保护作用均被显着抑制。结果表明,YC-1可能由于诱导Hsp70过表达而提高生存率。 ? 2012 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号